Short-latency neck muscle responses to vertical body tilt in normal subjects and in patients with spasmodic torticollis

Electroencephalography and Clinical Neurophysiology
L Mazzini, M Schieppati

Abstract

EMG responses in the sternocleidomastoid (SCM) and dorsal neck muscles (DNM) to vertical head acceleration were studied in normal subjects and in patients with spasmodic torticollis, standing on a platform that could be tilted upwards. The vertical body displacement and the induced changes in the head-neck angle (a flexion-extension sequence) were recorded. Excitatory responses, symmetrical on the two sides, were elicited in normal subjects in both muscle groups, at a latency of about 60 msec (DNM) and 90 msec (SCM). With the head initially extended, the latency of DNM response increased, leaving that of SCM unchanged. During an isometric rotatory effort, an early inhibitory period was recorded in the active muscles at a latency of about 40 msec. Downward tilt did not evoke the responses. The DNM excitatory responses appeared to be related to muscle stretch, while those in SCM, as well as the inhibitory responses in both muscles, were thought to originate in the vestibular receptors. During active head rotation the response increased in amplitude in the active SCM and decreased in the lengthened antagonist; decreased responses in the lengthened muscle persisted during passive head rotation. This was attributed to an influence f...Continue Reading

References

Jan 1, 1992·Journal of Neurology·G DeuschlW Poewe
Aug 1, 1991·Brain : a Journal of Neurology·P BrownC D Marsden
May 1, 1988·Electroencephalography and Clinical Neurophysiology·M C DoS Bouisset
Jan 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·R StellC D Marsden
Jan 1, 1989·Movement Disorders : Official Journal of the Movement Disorder Society·M Gresty
Feb 1, 1988·Archives of Neurology·S G DiamondR W Baloh
Jan 1, 1988·Experimental Brain Research·E A KeshnerB Debu
Mar 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·A M Bronstein, P Rudge
Jan 1, 1986·Experimental Brain Research·D GuittonB W Peterson
Jan 1, 1987·Movement Disorders : Official Journal of the Movement Disorder Society·M Gresty
Jun 1, 1985·Brain : a Journal of Neurology·C D MarsdenA E Lang
Sep 1, 1963·Brain : a Journal of Neurology·S COOPER, P M DANIEL

❮ Previous
Next ❯

Citations

Jul 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J Valls-SoléF Valldeoriola
Oct 3, 2003·Neuroscience·M SchieppatiM Schmid
Aug 26, 1998·Archives of Physical Medicine and Rehabilitation·A NardoneM Schieppati
Mar 31, 2015·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Vito Enrico PettorossiMarco Schieppati
Apr 13, 2020·Experimental Brain Research·Alyssa C DyballSally M Rosengren
Jul 18, 2001·Journal of Applied Physiology·M BoveM Schieppati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.